Rhelion Life Sciences Corp. (RHEL)
CSE
Closed
Sep 11, 2026
Day's Range
0.030052 wk Range
0.0250Profile - RHEL - Rhelion Life Sciences Corp.
Profile
Mic Code
XCNQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
0
Rhelion Life Sciences Corp. is a life sciences company focused on the research, development, and commercialization of natural psychedelic medicines and related products. The company operates a pharmaceutical development platform through its subsidiary Filament Health, where it advances naturally derived psilocybin candidates for psychiatric and neurological conditions and supports clinical research and compassionate-use programs. In parallel, Rhelion participates in the legal adult-use market in the Netherlands, where it sells psilocybin truffles through regulated consumer channels. Based in Toronto, Canada, the company combines drug discovery, product development, and market participation within the emerging psychedelic sector, positioning itself at the intersection of healthcare innovation and regulated natural medicine development.
Profile Details
Type
Common Stock
Ceo
Mr. Todd Michael Shapiro
Address
1 Adelaide Street East
City
Toronto
State
ON
Zip
M5C 2V9
Country
Canada
Phone
647 204 7129
Key Executives - RHEL - Rhelion Life Sciences Corp.
Key executives
Cross Listings - RHEL - Rhelion Life Sciences Corp.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
